Perioperative medication withholding in patients disease: A retrospective electronic health records review

Kathleen Fagerlund, Lisa C Anderson, Olga V Gurvich

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Background: Carbidopa-levodopa (Sinemet), the gold-standard treatment for Parkinson's disease, has a short half-life of one to two hours. When patients with Parkinson's disease are placed on npo (nil per os, or nothing by mouth) status for surgery, they may miss several doses of carbidopa-levodopa, possibly result-ing in exacerbation of Parkinson's disease symptoms. Clear guidelines regarding perioperative symptom management are lacking. Objectives: The goals of this study were threefold: to measure the perioperative duration of the with-holding of carbidopa-levodopa in patients with Parkinson's disease, to record the time of day surgeries were performed on these patients, and to record perioperative exacerbations of Parkinson's disease symp- toms. Methods: We conducted a retrospective review of patient electronic health records at a Midwestern public medical center. After applying inclusion and exclusion criteria and evaluating the eligible records, we had a final sample of 89 separate surgical events for 67 discrete patients who had been diagnosed with Parkinson's disease, had undergone any type of surgery excepting Parkinson's disease surgeries, and were taking carbidopa-levodopa. Results: The median duration of carbidopa-levodopa withholding was 12.35 hours, with most surgi-cal procedures (86%) starting at 9 am or later. The most commonly reported exacerbation of Parkinson's disease symptoms was agitation or confusion. Conclusions: For best symptom management, careful consideration should be given to scheduling sur-gery at the earliest possible time, administering medications as close to the patient's usual dosing sched-ule as possible, and providing nursing education about optimal medication management for this patient population.

Original languageEnglish (US)
Pages (from-to)26-35
Number of pages10
JournalAmerican Journal of Nursing
Volume113
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Electronic Health Records
Parkinson Disease
Nursing Education
Ambulatory Surgical Procedures
Gold
Half-Life
Mouth
levodopa drug combination carbidopa
Guidelines
Population

Keywords

  • Parkinson's disease
  • anesthesia
  • carbidopa-levodopa
  • medication management
  • periopera-tive complications
  • symptom management

Cite this

Perioperative medication withholding in patients disease : A retrospective electronic health records review. / Fagerlund, Kathleen; Anderson, Lisa C; Gurvich, Olga V.

In: American Journal of Nursing, Vol. 113, No. 1, 01.01.2013, p. 26-35.

Research output: Contribution to journalReview article

@article{4e671338c5e04695a745f5a381dfc4a2,
title = "Perioperative medication withholding in patients disease: A retrospective electronic health records review",
abstract = "Background: Carbidopa-levodopa (Sinemet), the gold-standard treatment for Parkinson's disease, has a short half-life of one to two hours. When patients with Parkinson's disease are placed on npo (nil per os, or nothing by mouth) status for surgery, they may miss several doses of carbidopa-levodopa, possibly result-ing in exacerbation of Parkinson's disease symptoms. Clear guidelines regarding perioperative symptom management are lacking. Objectives: The goals of this study were threefold: to measure the perioperative duration of the with-holding of carbidopa-levodopa in patients with Parkinson's disease, to record the time of day surgeries were performed on these patients, and to record perioperative exacerbations of Parkinson's disease symp- toms. Methods: We conducted a retrospective review of patient electronic health records at a Midwestern public medical center. After applying inclusion and exclusion criteria and evaluating the eligible records, we had a final sample of 89 separate surgical events for 67 discrete patients who had been diagnosed with Parkinson's disease, had undergone any type of surgery excepting Parkinson's disease surgeries, and were taking carbidopa-levodopa. Results: The median duration of carbidopa-levodopa withholding was 12.35 hours, with most surgi-cal procedures (86{\%}) starting at 9 am or later. The most commonly reported exacerbation of Parkinson's disease symptoms was agitation or confusion. Conclusions: For best symptom management, careful consideration should be given to scheduling sur-gery at the earliest possible time, administering medications as close to the patient's usual dosing sched-ule as possible, and providing nursing education about optimal medication management for this patient population.",
keywords = "Parkinson's disease, anesthesia, carbidopa-levodopa, medication management, periopera-tive complications, symptom management",
author = "Kathleen Fagerlund and Anderson, {Lisa C} and Gurvich, {Olga V}",
year = "2013",
month = "1",
day = "1",
doi = "10.1097/01.NAJ.0000425744.76107.9f",
language = "English (US)",
volume = "113",
pages = "26--35",
journal = "American Journal of Nursing",
issn = "0002-936X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Perioperative medication withholding in patients disease

T2 - A retrospective electronic health records review

AU - Fagerlund, Kathleen

AU - Anderson, Lisa C

AU - Gurvich, Olga V

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Background: Carbidopa-levodopa (Sinemet), the gold-standard treatment for Parkinson's disease, has a short half-life of one to two hours. When patients with Parkinson's disease are placed on npo (nil per os, or nothing by mouth) status for surgery, they may miss several doses of carbidopa-levodopa, possibly result-ing in exacerbation of Parkinson's disease symptoms. Clear guidelines regarding perioperative symptom management are lacking. Objectives: The goals of this study were threefold: to measure the perioperative duration of the with-holding of carbidopa-levodopa in patients with Parkinson's disease, to record the time of day surgeries were performed on these patients, and to record perioperative exacerbations of Parkinson's disease symp- toms. Methods: We conducted a retrospective review of patient electronic health records at a Midwestern public medical center. After applying inclusion and exclusion criteria and evaluating the eligible records, we had a final sample of 89 separate surgical events for 67 discrete patients who had been diagnosed with Parkinson's disease, had undergone any type of surgery excepting Parkinson's disease surgeries, and were taking carbidopa-levodopa. Results: The median duration of carbidopa-levodopa withholding was 12.35 hours, with most surgi-cal procedures (86%) starting at 9 am or later. The most commonly reported exacerbation of Parkinson's disease symptoms was agitation or confusion. Conclusions: For best symptom management, careful consideration should be given to scheduling sur-gery at the earliest possible time, administering medications as close to the patient's usual dosing sched-ule as possible, and providing nursing education about optimal medication management for this patient population.

AB - Background: Carbidopa-levodopa (Sinemet), the gold-standard treatment for Parkinson's disease, has a short half-life of one to two hours. When patients with Parkinson's disease are placed on npo (nil per os, or nothing by mouth) status for surgery, they may miss several doses of carbidopa-levodopa, possibly result-ing in exacerbation of Parkinson's disease symptoms. Clear guidelines regarding perioperative symptom management are lacking. Objectives: The goals of this study were threefold: to measure the perioperative duration of the with-holding of carbidopa-levodopa in patients with Parkinson's disease, to record the time of day surgeries were performed on these patients, and to record perioperative exacerbations of Parkinson's disease symp- toms. Methods: We conducted a retrospective review of patient electronic health records at a Midwestern public medical center. After applying inclusion and exclusion criteria and evaluating the eligible records, we had a final sample of 89 separate surgical events for 67 discrete patients who had been diagnosed with Parkinson's disease, had undergone any type of surgery excepting Parkinson's disease surgeries, and were taking carbidopa-levodopa. Results: The median duration of carbidopa-levodopa withholding was 12.35 hours, with most surgi-cal procedures (86%) starting at 9 am or later. The most commonly reported exacerbation of Parkinson's disease symptoms was agitation or confusion. Conclusions: For best symptom management, careful consideration should be given to scheduling sur-gery at the earliest possible time, administering medications as close to the patient's usual dosing sched-ule as possible, and providing nursing education about optimal medication management for this patient population.

KW - Parkinson's disease

KW - anesthesia

KW - carbidopa-levodopa

KW - medication management

KW - periopera-tive complications

KW - symptom management

UR - http://www.scopus.com/inward/record.url?scp=84871977426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871977426&partnerID=8YFLogxK

U2 - 10.1097/01.NAJ.0000425744.76107.9f

DO - 10.1097/01.NAJ.0000425744.76107.9f

M3 - Review article

C2 - 23247677

AN - SCOPUS:84871977426

VL - 113

SP - 26

EP - 35

JO - American Journal of Nursing

JF - American Journal of Nursing

SN - 0002-936X

IS - 1

ER -